Education
About Us
Working with TipRanks
Follow Us
Siemens Healthineers AG (SEMHF)
OTHER OTC:SEMHF
RESEARCH TOOLSreports
SEMHF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$46.29 - $62.00
Previous CloseN/A
Volume16.00
Average Volume (3M)293.00
Market Cap
$58.84B
Enterprise Value$53.61B
Total Cash (Recent Filing)$2.85B
Total Debt (Recent Filing)€808.00M
Price to Earnings (P/E)25.9
Beta0.75
Next Earnings
Jul 30, 2025EPS Estimate
0.6Last Dividend Ex-Date
Feb 19, 2025Dividend Yield2.01%
Share Statistics
EPS (TTM)0.63
Shares Outstanding1,128,000,000
10 Day Avg. Volume112
30 Day Avg. Volume293
Financial Highlights & Ratios
PEG Ratio-1.24
Price to Book (P/B)2.97
Price to Sales (P/S)0.00
P/FCF Ratio21.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$69.87Price Target Upside32.13% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
Siemens Healthineers AG News
PremiumCompany Announcements
Siemens Healthineers Q2 Earnings: Growth Amid Challenges
PremiumCompany Announcements
Siemens Healthineers Q1 2025 Earnings Call Insights
PremiumCompany Announcements
Siemens Healthineers Reports Robust Q1 2025 Performance
PremiumCompany Announcements
Siemens Healthineers Reports Strong Fiscal Year 2024Bulls Say, Bears Say
Bulls Say
Free Cash FlowFree cash flow was EUR197mn, up 64% y/y, significantly higher than the previous year, supporting continued investment in innovation and shareholder returns.
InnovationSiemens Healthineers is at the forefront of innovation and was the first company to obtain FDA approval for the first photon-counting CT for clinical use and continues to be the only company with such technology commercially available.
Revenue GrowthRevenue grew 6.8% y/y to EUR5.9bn, beating full-year guidance of 5% to 6%.
Bears Say
Advanced Therapies SegmentAdvanced therapies segment showed a margin below expectations, attributed to an unfavorable business mix.
Diagnostics Segment PerformanceDiagnostics revenue growth was modest and the adjusted EBIT was materially below expectations.
Tariffs And Trade BarriersThe adjusted EPS forecast range was widened from EUR2.35 to EUR2.50 originally to EUR2.20 to EUR2.50 to factor in anticipated impacts from tariffs and trade barriers which may affect operations in key markets.
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
3.17% Mutual Funds
― Other Institutional Investors
93.60% Public Companies and
Individual Investors
SEMHF FAQ
What was Siemens Healthineers AG’s price range in the past 12 months?
Siemens Healthineers AG lowest stock price was $46.29 and its highest was $62.00 in the past 12 months.
What is Siemens Healthineers AG’s market cap?
Siemens Healthineers AG’s market cap is $58.84B.
When is Siemens Healthineers AG’s upcoming earnings report date?
Siemens Healthineers AG’s upcoming earnings report date is Jul 30, 2025 which is in 53 days.
How were Siemens Healthineers AG’s earnings last quarter?
Siemens Healthineers AG released its earnings results on May 07, 2025. The company reported $0.627 earnings per share for the quarter, missing the consensus estimate of $0.633 by -$0.007.
Is Siemens Healthineers AG overvalued?
According to Wall Street analysts Siemens Healthineers AG’s price is currently Undervalued.
Does Siemens Healthineers AG pay dividends?
Siemens Healthineers AG pays a Annually dividend of $1.083 which represents an annual dividend yield of 2.01%. See more information on Siemens Healthineers AG dividends here
What is Siemens Healthineers AG’s EPS estimate?
Siemens Healthineers AG’s EPS estimate is 0.6.
How many shares outstanding does Siemens Healthineers AG have?
Siemens Healthineers AG has 1,128,000,000 shares outstanding.
What happened to Siemens Healthineers AG’s price movement after its last earnings report?
Siemens Healthineers AG reported an EPS of $0.627 in its last earnings report, missing expectations of $0.633. Following the earnings report the stock price went down -3.346%.
Which hedge fund is a major shareholder of Siemens Healthineers AG?
Currently, no hedge funds are holding shares in SEMHF
Siemens Healthineers AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$69.87 (32.13% Upside)
$69.87 (32.13% Upside)
Blogger Sentiment
Bullish
SEMHF Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $280.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.13%
12-Months-Change
Fundamentals
Return on Equity
11.14%
Trailing 12-Months
Asset Growth
1.24%
Trailing 12-Months
Company Description
Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
SEMHF Company Deck
SEMHF Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a strong performance with significant growth in revenue, order intake, and segment advancements. However, challenges such as the tariff environment and specific segment pressures, particularly in Varian, were noted. While the company is taking measures to mitigate these challenges, the ongoing uncertainty in the global trade environment presents a cautious outlook.Read More>SEMHF Stock 12 Month Forecast
Average Price Target
$69.87
▲(32.13%Upside)
Technical Analysis
Carl Zeiss Meditec
―
Fresenius Medical Care AG & Co. KGaA
―
Fresenius SE & Co. KGaA
―
Merck KGaA
―
Sartorius
―